Towards ending Malaria in the sub-Saharan Africa: Is the RTS, S Malaria Vaccine really a game changer?

Introduction The WHO declaration of RTS, S malaria vaccine on 6th October 2021 for extensive use among children in sub-Saharan Africa has been hailed as a “game changer” towards eliminating malaria burden by 90% by 2030.  “This long-awaited malaria vaccine is a breakthrough for science, child health and malaria control,” said WHO director-general Tedros Adhanom…

The African Constituency Bureau Discusses with TB High Burden Countries the Global Fund Disease Split and The TB Fight

The ACB has engaged in technical discussions with country implementers and CCMs of six countries with high burden of TB, HIV/TB and MDR-TB in Africa burden countries to better understand their situation and potential solutions on how to reduce TB burden without affecting malaria and HIV programs negatively. Countries involved in these discussions that were held virtually on 26th August 2021 are [1]Kenya, Nigeria, Sierra Leone, Tanzania, Zimbabwe and South Africa. The input of these countries and other ongoing consultations will help determine a position that reflects the possible variety of situations across the 46 countries of both our ESA and WCA constituencies.